Curis
CRIS
#10292
Rank
C$15.4 M
Marketcap
C$1.19
Share price
-2.90%
Change (1 day)
-76.81%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -C$45.86 Million

According to Curis's latest financial reports the company's current earnings are C$11.65 Million. In 2024 the company made an earning of -C$58.44 Million, an increase over its 2023 earnings that were of -C$62.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$45.86 Million-21.53%
2024 -C$58.44 Million-5.77%
2023 -C$62.02 Million-13.1%
2022 -C$71.36 Million27.52%
2021 -C$55.97 Million65.09%
2020 -C$33.9 Million-9.1%
2019 -C$37.29 Million-4.73%
2018 -C$39.14 Million-41.95%
2017 -C$67.42 Million-14.37%
2016 -C$78.74 Million3.55%
2015 -C$76.04 Million271.52%
2014 -C$20.47 Million76.64%
2013 -C$11.59 Million
2011 -C$9.84 Million27.76%
2010 -C$7.71 Million-43.87%
2009 -C$13.73 Million-23.44%
2008 -C$17.93 Million56.66%
2007 -C$11.45 Million-16.71%
2006 -C$13.74 Million-36.92%
2005 -C$21.78 Million156.25%
2004 -C$8.5 Million-37.24%
2003 -C$13.55 Million-93.34%
2002 -C$0.21 Billion86.79%
2001 -C$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$16.19 B-36,502.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$10.97 B-24,772.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-C$84.54 Million 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$1.19 B-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.36 Billion 687.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-C$33.83 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.22 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA